The impact of COVID-19 infection of patients with autoimmune blistering diseases of the skin
The impact of COVID-19 infection of patients with autoimmune blistering diseases of the skin

Summary/Abstract: Nowadays, it is an uncertain time for the whole world, firmly under the grip of a tiny virus,thought to have originated in China. The disease caused by the SARS-CoV-2 virus wastermed Coronavirus disease/COVID-19. As dermatologists, we are impacted in multiple waysin the COVID-19 pandemic and have a significant role to play. Autoimmune blisteringdiseases (AIBD) are a miscellaneous group of disorders associated with autoantibodiesdirected against distinct desmosomal structural proteins, hemidesmosome structural proteins,or epidermal/tissue transglutaminase. AIBD patients need continuous hospital monitoring,and during this period affected by the pandemic with COVID-19, their physical and mentalcondition suffered. The cutaneous damage such as bullae formation, pain, itch, and associatedfunctional limitations have a psycho-emotional impact on patients and can severely affect thepatient’s quality of life.

• Details
• Contents